As per our report, the Latin America Patient Monitoring market was estimated at USD 3.30 Billion in 2022. It is further expected to worth USD 4.76 Billion by 2027, registering a CAGR of 7.60% from 2022 to 2027.
Patient Monitoring Systems enable efficient healthcare delivery to patients outside the conventional hospital or clinical settings by transmitting real-time patient data for clinical review, which reduces mortality rates and facilitates efficient use of medical resources. These patient monitoring services help avoid emergency overcrowding, manage a huge number of patients, and enhance electronic health records (EHR). Recently the market has gained immense focus due to the government measures to cut down hospital expenditures and reduce hospital stays.
The Latin American Patient monitoring market is expected to be majorly driven by the rising prevalence of chronic diseases, increasing the number of surgeries, and growing demand for monitoring devices across the region. Another factor projected to drive market expansion is rapid improvements in the electronics sector, which have resulted in device shrinking and manufacturers' approach to the development of advanced small portable devices that aid in emergencies.
In addition, the growing geriatric population is significantly influencing the LATAM Patient monitoring market. The senior population is more prone to various chronic diseases, such as cancer, diabetes, and other cardiovascular disorders, enabling monitoring devices. According to the Cancer Atlas report, over 1.3 million new cancer cases and 666,000 cancer deaths occurred in Latin America and the Caribbean in 2018. As a result, using these ensures that the patient's condition is constantly checked. Furthermore, one of the primary drivers of market expansion is the necessity to sustain average healthcare expenditures.
Other factors such as increasing healthcare spending, improving healthcare expenditure, and the availability of advanced healthcare infrastructure in emerging countries contribute to Latin America Patient Monitoring market growth.
Moreover, growing government spending in the healthcare sector to enable the use of innovative technology is expected to encourage new market entrants.
Furthermore, with the introduction of smart connected devices and high-speed internet access, Increased usage of wireless devices for remote monitoring by hospitals and clinics is likely to boost the market growth.
However, the high cost of various monitoring equipment and technical issues are projected to hinder the adoption of advanced monitoring devices, posing a significant challenge for the Latin American Patient monitoring market.
Stringent government regulations governing product certification and a lack of built infrastructure in Latin American countries are expected to hinder the market growth.
Other factors projected to drive market expansion include an increase in the usage of smart wearables that can track and exchange monitored data with healthcare practitioners and an increase in the global geriatric population, and a desire for home healthcare.
This research report on the Latin America Patient Monitoring Market has been segmented and sub-segmented into the following categories:
Transcranial Doppler (TCD)
Intracranial Pressure Monitors (ICP)
Hemodynamic Monitoring Devices
Blood Pressure Monitors
Blood Glucose Monitors
Blood Gas and Electrolyte Analyzers
Cardiac Monitoring Devices
Implantable Loop Recorder (ILR)
Cardiac Output Monitoring Devices
Fetal and neonatal Monitoring Devices
UltraSound Fetal Dopplers
Internal Fetal Monitors
Respiratory Monitoring Devices
Sleep Apnea Monitoring Devices
Multi-Parameter Monitoring Devices
Temperature Monitoring Devices
Weight Monitoring Devices
Remote Patient Monitoring Devices
Rest of Latin America
The Latin America patient monitoring market is predicted to witness a moderate share during the forecast period. The Latin American patient monitoring market is expected to grow at a CAGR of 3.3 percent during the projected period. The regional market growth is expected to be fueled by a well-established healthcare sector, favorable reimbursement policies, and the presence of key market players. In addition, the presence of large companies in countries like Mexico, Brazil, and Argentina and a well-developed healthcare infrastructure expand the Latin American regional market growth.
In addition, the region's market growth is likely to be aided by increased merger and acquisition activity between regional and international businesses.
Brazil dominates the LATAM patient monitoring market, and it is likely to continue its growth over the forecast period. The rising burden of chronic diseases as a result of lifestyle changes and the expanding preference for home and remote monitoring are two important reasons driving the market growth.
On the other hand, emerging countries such as Argentina and Mexico are more likely to grow significantly due to the improving healthcare sectors, healthcare expenditure, and supportive government policies. In addition to the significant prevalence of various chronic conditions, patient monitoring technologies are used to detect slight changes in the patient's physiological data; hence, encouraging self-monitoring is the other factor propelling the growth of Latin America patient monitoring market.
Companies playing a notable role in the Latin America Patient Monitoring Market are Abbott Laboratories, Masimo Corporation, Covidien, Drager Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org